Technology | March 11, 2010

Hemostatis Products Use Thrombin to Curb Bleeding

D-Stat Dry

Vascular Solutions offers a variety of hemostasis products used to stop bleeding. D-Stat products rely on biologically active components to induce bleeding cessation.The products use thrombin, a natural component of the clotting cascade. Thrombin cleaves fibrinogen to fibrin, enhancing the body's own ability to produce clot.

D-Stat Dry
D-Stat Dry is a topical hemostatic bandage used to control surface bleeding from vascular access sites following percutaneous procedures. It relies on the science and clotting power of thrombin to activate clotting factors VII, V and XII.

Clinical results from a 376-patient, five-center, prospective randomized U.S. clinical study showed that D-Stat Dry reduces the time to hemostasis compared with standard manual compression alone. The study evaluated D-Stat Dry as an adjunct to hemostasis in diagnostic femoral catheterizations using 4F-6F introducer sheaths.

Stat Dry Wrap
A convenient pre-cut version of D-Stat Dry, D-Stat Dry Wrap is designed specifically for the control of bleeding around indwelling lines. It contains the same thrombin activity level as the original D-Stat Dry, and comes complete with a clear adhesive bandage for continuous site monitoring after hemostasis is achieved.

Stat 2 Dry
D-Stat 2 Dry is a convenient two-bandage version of the D-Stat Dry hemostatic bandage. The pad contains the same thrombin activity level as the original D-Stat Dry, but can be separated in two for application on two separate puncture sites.

The products are contraindicated in persons with known sensitivity to bovine-derived materials.

For more information:

Related Content

Merit Medical Launches PreludeSync Evo Radial Compression Device
News | Hemostasis Management | August 29, 2019
Merit Medical Systems Inc. announced the U.S. commercial launch of the PreludeSync Evo radial compression device. The...
PreludeSync Distal Compression Device Available Globally
Technology | Hemostasis Management | February 01, 2019
Merit Medical Systems Inc. announced that the PreludeSync Distal Compression Device is now available in the United...
nanoparticles, blood clotting, internal bleeding, American Chemical Society study, Erin B. Lavik

Nanoparticles (green) help form clots in an injured liver. The researchers added color to the scanning electron microscopy image after it was taken. Image courtesy of Erin Lavik, Ph.D.

News | Hemostasis Management | August 24, 2016
August 24, 2016 — Whether severe trauma occurs on the battlefield or the highway, saving lives often comes down to...
News | Hemostasis Management | January 06, 2016
The Medicines Company announced Dec. 18 it has entered into a purchase agreement pursuant to which certain subsidiaries...